FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis
暂无分享,去创建一个
Ying Wang | Kounosuke Watabe | Sucharita Bandyopadhyay | K. Miura | Ken Saito | S. Markwell | M. Watabe | S. Hirota | S. Hosobe | K. Watabe | Megumi Iiizumi | M. Pauza | Ying Wang | S. K. Pai | Jodi Huggenvik | Stephen J Markwell | Sudha K Pai | Misako Watabe | Steven C Gross | Shigeru Hirota | Sadahiro Hosobe | Taisei Tsukada | Kunio Miura | Ken Saito | Mary E Pauza | Megumi Iiizumi | Sudha K. Pai | J. Huggenvik | S. Bandyopadhyay | S. Gross | T. Tsukada | Kunio Miura | Sucharita Bandyopadhyay
[1] F. Kuhajda. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. , 2000, Nutrition.
[2] A. Nashimoto,et al. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach , 2002, Histopathology.
[3] R. Seeley,et al. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. , 2002, Diabetes.
[4] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[5] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Nelson,et al. Increased fatty acid synthase as a therapeutic target in androgen‐independent prostate cancer progression , 2001, The Prostate.
[7] P. Morin,et al. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. , 2002, Experimental cell research.
[8] G. Mick,et al. Inhibitory effects of cerulenin on protein palmitoylation and insulin internalization in rat adipocytes. , 1995, Biochimica et biophysica acta.
[9] J. Swinnen,et al. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway , 2000, Oncogene.
[10] C. Bosman,et al. Fatty acid synthase expression in melanoma , 2003, Journal of cutaneous pathology.
[11] J. Nelson,et al. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model , 2003, The Prostate.
[12] Kanji A. Takahashi,et al. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator. , 2004, Endocrinology.
[13] E. Malvoisin,et al. Effect of drugs which inhibit cholesterol synthesis on syncytia formation in vero cells infected with measles virus. , 1990, Biochimica et biophysica acta.
[14] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[15] P. Visca,et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients , 1996, Cancer.
[16] A W Partin,et al. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. , 1995, Urology.